| DIrect Oral Anticoagulation and Bioprothesis Aortic Valve (NCT05687448) | Assistance Publique - Hôpitaux de Paris | 2025-09-01 |
| Autologous Cold-stored Apheresis Platelets (NCT07064954) | University Health Network, Toronto | 2025-09-01 |
| Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock (NCT07129031) | Xijing Hospital | 2025-09-01 |
| High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy (NCT07213375) | Rigshospitalet, Denmark | 2025-09-01 |
| Nintedanib for Improving Reproductive Outcomes in Adenomyosis (NCT07162961) | Sun Yat-sen University | 2025-09-01 |
| Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness (NCT06282315) | Insud Pharma | 2025-09-01 |
| Oral Paclitaxel + Encequidar vs IV Paclitaxel in Treatment of HER2 Negative Metastatic Breast Cancer (NCT06835400) | Health Hope Pharma | 2025-09-01 |
| A Trial to Assess Efficacy and Safety of ex Vivo Allograft Admin of iCM012 Solution 2 mg/ml to Improve Its Function in Recipients of DCD Kidneys (NCT06582485) | iCoat Medical AB | 2025-09-01 |
| A Clinical Comparison of Connective Tissue Graft and Alb-PRF for Rebuilding Interdental Papilla (NCT07139392) | shaimaa hamdy | 2025-09-01 |
| A Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard Continuous Venetoclax Exposure Combined With Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction (NCT07082452) | Gustave Roussy, Cancer Campus, Grand Paris | 2025-09-01 |
| Methylprednisolone for Stroke With Large Infarct Core and Post-stroke Lymphocytopenia (NCT07202143) | YiLin | 2025-09-01 |
| Bifocal Spectacles vs. Single Vision Spectacles for Esotropia Greater at Near (NCT05527015) | Jaeb Center for Health Research | 2025-09-01 |
| Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients (NCT07132684) | Institute of Hematology & Blood Diseases Hospital, China | 2025-08-31 |
| Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency (NCT07126288) | Shenzhen Kexing Pharmaceutical Co., Ltd. | 2025-08-31 |
| A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone (NCT07139535) | Guangdong Raynovent Biotech Co., Ltd | 2025-08-31 |
| A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes (NCT07139548) | Guangdong Raynovent Biotech Co., Ltd | 2025-08-31 |
| A Study to Evaluate the Effects and Safety of Hydroxocobalamin in Participants With Combined Methylmalonic Academia (cblC Type) (NCT07163364) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2025-08-31 |
| Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia (NCT07157722) | Tanta University | 2025-08-30 |
| Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms (NCT06803030) | Bir Hospital | 2025-08-30 |
| TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders (NCT07377032) | Meyer Children's Hospital IRCCS | 2025-08-29 |
| Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors (NCT07165886) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2025-08-29 |
| Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type (NCT07066826) | Wanbangde Pharmaceutical Group Co., LTD | 2025-08-29 |
| A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis (NCT07237568) | Lynk Pharmaceuticals Co., Ltd | 2025-08-29 |
| Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients. (NCT07443397) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-08-29 |
| Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma (NCT06841679) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2025-08-28 |
| Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps (NCT07132827) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-08-28 |
| STOP-HAE: A Phase 3 Study of ADX-324 in HAE (NCT06960213) | ADARx Pharmaceuticals, Inc. | 2025-08-28 |
| Head and Neck Cancer Study Project in the Geriatric Population (NCT06998069) | Brown University | 2025-08-27 |
| Efficacy and Safety of Tocilizumab for Acute Chest Syndrome Treatment in Patients With Sickle Cell Disease (NCT06818266) | Assistance Publique - Hôpitaux de Paris | 2025-08-27 |
| A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2) (NCT07200908) | Mirum Pharmaceuticals, Inc. | 2025-08-27 |
| A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States (NCT07122193) | Merz North America, Inc. | 2025-08-27 |
| A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (NCT07043400) | BeOne Medicines | 2025-08-27 |
| Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer (NCT06982521) | Relay Therapeutics, Inc. | 2025-08-26 |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections. (NCT06925321) | Basilea Pharmaceutica | 2025-08-26 |
| 3°C Saline Injection at the Duodenal Papilla to Prevent Post-ERCP Pancreatitis (NCT07381478) | Universidad Nacional de Colombia | 2025-08-26 |
| RSV Immunogenicity Study in the Elderly (RISE) (NCT07203365) | Karin Karin Loré | 2025-08-25 |
| A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected Severe Gram-negative Bacterial Infections (NCT07063095) | Angela HUTTNER | 2025-08-25 |
| Epidemiology and Biomarker Study in Alzheimer's Disease (NCT07142954) | Eli Lilly and Company | 2025-08-25 |
| BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies (NCT07160244) | Pfizer | 2025-08-25 |
| Co-administration of Calcium and Multiple Micronutrient Supplements for Maternal and Newborn Hemoglobin and Iron Status (NCT06568315) | Johns Hopkins Bloomberg School of Public Health | 2025-08-25 |
| Endoscopic Therapy Or Surgery for Early Colon Cancer (NCT06940947) | Norwegian Department of Health and Social Affairs | 2025-08-25 |
| CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC (NCT07383246) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-08-25 |
| A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP (NCT06920004) | argenx | 2025-08-22 |
| Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures (NCT07120763) | State University of New York at Buffalo | 2025-08-22 |
| OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events (NCT07136012) | Amgen | 2025-08-22 |
| Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer (NCT06952920) | Jiuda Zhao | 2025-08-21 |
| Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV) (NCT07154706) | Nuvation Bio Inc. | 2025-08-21 |
| A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029) (NCT07058077) | Merck Sharp & Dohme LLC | 2025-08-21 |
| A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine (NCT07018713) | Merz Therapeutics GmbH | 2025-08-21 |
| Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer (NCT06958328) | NRG Oncology | 2025-08-21 |
| A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine (NCT07018700) | Merz Therapeutics GmbH | 2025-08-21 |
| Comparative Study of Nutraceuticals vs. Conventional Prophylactic Therapy in the Management of Migraine (NCT07147972) | Fayoum University | 2025-08-20 |
| Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients (NCT06750458) | Tanta University | 2025-08-20 |
| Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer (NCT07188584) | Ming-Yuan Chen | 2025-08-20 |
| A Study of Pitolisant in Participants With Prader-Willi Syndrome (NCT07219485) | Harmony Biosciences Management, Inc. | 2025-08-20 |
| Clinical Trial Protocol: Randomized Placebo-Controlled Pilot Study of GcMAF (Soloways TM) in Patients With Metastatic Breast Cancer (NCT06434077) | S.LAB (SOLOWAYS) | 2025-08-20 |
| A Clinical Study to Assess the Effectiveness of ENO Lime in Participants With Ajeerna Vyadhi (Acidity, Acid Indigestion, Indigestion, and Associated Nausea) (NCT07140341) | HALEON | 2025-08-20 |
| High Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD): to Load or Maintain (HEIRLOOM) (NCT07129239) | Clinique de Retine de l'est | 2025-08-20 |
| Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer (NCT07150663) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2025-08-20 |
| A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer (NCT07111832) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2025-08-20 |
| Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity (NCT07001748) | ECOG-ACRIN Cancer Research Group | 2025-08-19 |
| Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis (NCT07111468) | Yuhan Corporation | 2025-08-19 |
| To Assess the Efficacy of a Toothpaste Containing 8% Arginine as Compared to Colgate Cavity Protection Toothpaste in the Reduction of Dentinal Hypersensitivity. (NCT07149376) | Colgate Palmolive | 2025-08-18 |
| A Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patients With Gastric or Gastroesophageal Junction Adenocarcinoma (NCT07118527) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2025-08-18 |
| A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia (NCT07086976) | Sanofi | 2025-08-18 |
| A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) (NCT07196501) | Neurocrine Biosciences | 2025-08-18 |
| A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) (NCT07005128) | Amgen | 2025-08-18 |
| Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Stage IV Colon Cancer Patients Undergoing First-Line Chemotherapy (NCT07669519) | Natureceuticals Sdn Bhd | 2025-08-18 |
| Clinical Investigation of PerioGard (Test) Regimen (NCT07210138) | Colgate Palmolive | 2025-08-18 |
| PSMA PET Combined With MRI for the Detection of PCa (NCT07052214) | Telix Pharmaceuticals (Innovations) Pty Limited | 2025-08-18 |
| Effect of Different Anesthetic Drugs on Electrocorticography (ECOG). (NCT07165262) | Children's Cancer Hospital Egypt 57357 | 2025-08-18 |
| Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome (NCT07114055) | Md. Hazrat Ali | 2025-08-15 |
| A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis (NCT07154342) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2025-08-15 |
| V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency (NCT06954441) | On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. | 2025-08-15 |
| Home-based Cardiac Rehabilitation in Heart Failure (NCT06349941) | University of Texas Southwestern Medical Center | 2025-08-15 |
| Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma (NCT07125755) | Sun Yat-sen University | 2025-08-15 |
| Analgesic Efficacy of Pre-operative Dose of Ketorolac and Gabapentin (NCT07047040) | Assiut University | 2025-08-15 |
| Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer (NCT07067749) | University of Rome Tor Vergata | 2025-08-15 |
| KinesioTaping for Thoracic Drain Support (NCT07098962) | Kastamonu University | 2025-08-15 |
| A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma (NCT07023315) | Akeso | 2025-08-14 |
| Empowering Cessation ACS South Region (NCT06820034) | University of Oklahoma | 2025-08-14 |
| Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users (NCT07092709) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2025-08-14 |
| Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial (NCT07281508) | The Netherlands Cancer Institute | 2025-08-14 |
| A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia (NCT06948318) | Takeda | 2025-08-14 |
| A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP) (NCT07059000) | Kedrion S.p.A. | 2025-08-13 |
| Treating the Metabolic Syndrome With a Sodium-glucose Cotransporter-2 Inhibitor (NCT07065357) | The University of Hong Kong | 2025-08-13 |
| A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety (NCT07019922) | Praxis Precision Medicines | 2025-08-13 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Who Are on Positive Airway Pressure Ventilation (PAP) Therapy (NCT06994650) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2025-08-13 |
| A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma (NCT06952478) | Celltrion | 2025-08-12 |
| Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype (NCT06947967) | Chipscreen Biosciences, Ltd. | 2025-08-12 |
| Pharmacogenomics ANDA SNP Clinical Study - Topotecan and Single Nucleotide Polymorphisms (NCT07145333) | Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair | 2025-08-12 |
| The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease (NCT06975865) | Sanofi | 2025-08-12 |
| Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus (NCT07193459) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2025-08-12 |
| Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE) (NCT07246889) | Ausper Biopharma Co., Ltd. | 2025-08-12 |
| Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis (NCT07265297) | National Taiwan University Hospital | 2025-08-12 |
| NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia (NCT07105098) | Neurocrine Biosciences | 2025-08-11 |
| Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With PNH Who Have Clinically Significant Extravascular Hemolysis (NCT06449001) | Alexion Pharmaceuticals, Inc. | 2025-08-11 |
| A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) (NCT07099898) | GlaxoSmithKline | 2025-08-11 |
| A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes (NCT07076199) | Novo Nordisk A/S | 2025-08-11 |
| Choline and Iron Deficiency (NCT06527391) | University of Minnesota | 2025-08-11 |